ARCHIVES

In Brief: NCI Scientist Accused Of Taking ‘Payoffs’ Forom Drug Firms; GM-CS Wins FDA Approval

This article is from The Cancer Letter archive.

Vol. 17 No. 11 | March 15, 1991

Download PDF Visit The Full Archive

Related Articles

Recommendation By Patients; report Of Protocol Committee

August 9, 1996

Taxotere Encouraging, CPT-11, Other Agents Entering Trials; Chabner

July 10, 1992

NCI-Approved Clinical Trials

October 27, 2006

‘Major Discover’ At FCRDC Is NF1 Gene, Report Says

November 30, 1990

American Legacy Foundation Says Group is Fighting For Its Survival.

January 7, 2005

Translplants Not Best Choice in Subset of ALL Patients

April 27, 2012